Tag: Dr. Seth Bilazarian


Dr. Seth Bilazarian on the recent Circulation paper by Dr. Schrage/Dr. Ibrahim

Dr. Seth Bilazarian discusses a recent paper published in Circulation by Drs. Benedikt Schrage, Karim Ibrahim, et. al. on a retrospective matched-pair analysis comparing patients in cardiogenic shock treated with balloon pump and Impella. Dr. Bilazarian highlights several limitations of the analysis, which used a matched-pair analysis to “harmonize baseline characteristics” of Impella-treated patients with … Continue reading “Dr. Seth Bilazarian on the recent Circulation paper by Dr. Schrage/Dr. Ibrahim”

New Study Finds Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention

Specialist Opinion with Dr. Seth Bilazarian A new retrospective, single-center study published in Circulation Research finds use of hemodynamic support with Impella 2.5® heart pump during high-risk percutaneous coronary intervention (HRPCI) can reduce the risk of acute kidney injury (AKI) even when those patients had preexisting kidney disease and low ejection fraction (EF). The new … Continue reading “New Study Finds Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention”

Scripps 2015 Preview: Protected PCI to be Highlighted at Pre-Conference Seminar

2015_Cardiovascular_InterventionsThis year’s 26th annual 2015 Scripps Cardiovascular Interventions event will be held at the Hilton La Jolla Torrey Pines in La Jolla, California and will run from October 27-30. This event will demonstrate the latest advances in interventional cardiology through a “program of lectures from world experts, live demonstration procedures, and participant-faculty interactions." Continue readingScripps 2015 Preview: Protected PCI to be Highlighted at Pre-Conference Seminar